tiprankstipranks
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market
ADIL
Adial Pharmaceuticals
RESEARCH TOOLSreports

Adial Pharmaceuticals (ADIL) Financial Statements

606 Followers

Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently $2.34M. The company's EPS TTM is $-1.81; its P/E ratio is -0.46; Adial Pharmaceuticals is scheduled to report earnings on March 6, 2026, and the estimated EPS forecast is $-2.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -565.00$ 0.00$ -564.00$ 0.00$ 0.00
Operating Income$ -7.80M$ -8.28M$ -6.89M$ -10.86M$ -19.29M
EBITDA$ -7.80M$ -8.28M$ -7.00M$ -10.86M$ -17.69M
Net Income$ -7.98M$ -13.20M$ -7.00M$ -12.73M$ -19.42M
Balance Sheet
Cash & Short-Term Investments$ 5.88M$ 3.75M$ 2.83M$ 4.00M$ 6.06M
Total Assets$ 6.67M$ 5.04M$ 4.74M$ 5.73M$ 7.63M
Total Debt$ 0.00$ 0.00$ 0.00$ 207.38K$ 256.96K
Net Debt$ -5.88M$ -3.75M$ -2.83M$ -3.79M$ -5.81M
Total Liabilities$ 1.40M$ 975.86K$ 653.51K$ 2.46M$ 4.13M
Stockholders' Equity$ 5.28M$ 4.07M$ 4.08M$ 3.28M$ 3.51M
Cash Flow
Free Cash Flow$ -6.49M$ -6.92M$ 0.00$ -11.19M$ -12.01M
Operating Cash Flow$ -6.49M$ -6.92M$ -6.81M$ -11.19M$ -11.95M
Investing Cash Flow$ 150.00K$ 0.00$ 1.50M$ 0.00$ -34.02K
Financing Cash Flow$ 8.47M$ 7.85M$ 4.13M$ 9.13M$ 13.64M
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Income Statement >

Adial Pharmaceuticals Debt to Assets

Balance Sheet >

Adial Pharmaceuticals Cash Flow

Cash Flow >

Adial Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >